Skip to main content

Macrogen Europe: Bongcho Kim

Sequencing services provider Macrogen Europe has appointed Bongcho Kim as CEO. He has been tasked with expanding the company's sequencing and bioinformatics capabilities.

Kim was previously director of technology and innovation of Seoul-based Macrogen. He joined the firm in 2013 as general manager for next-generations sequencing overseas sales before being promoted to director and VP.

Kim holds a doctorate in pathology from Seoul National University.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.